https://www.selleckchem.com/products/osmi-1.html
Socioeconomic disadvantage may be an important contributor to clinical outcomes in MS but is not well understood. Our objective was to examine the associations between Area Deprivation Index (ADI), a validated measure of neighborhood-level disadvantage, with clinical outcomes. We assessed the longitudinal association between MS Performance Test (MSPT) and quality of life in Neurological Disorders (Neuro-QoL) measures with ADI quartiles (Q1 lowest deprivation - Q4 highest deprivation) in relapsing remitting MS (RRMS) and progressive MS co
Like
Comment
Share
